AbCellera Biologics Inc. (ABCL) Financials

ABCL Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2026 1.5 billion 437.4 million
June 30, 2026 1.3 billion 411.6 million
March 31, 2026 1.3 billion 369.0 million
Dec. 31, 2025 1.4 billion 390.0 million

ABCL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 25.3 million 11.7 million
June 30, 2026 -36.0 million 12.3 million
March 31, 2026 -37.4 million 12.0 million
Dec. 31, 2025 -44.6 million 12.9 million

ABCL Net Income

No data available :(

ABCL Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 764.4 million - 133.8 million
June 30, 2026 540.1 million - 135.6 million
March 31, 2026 504.7 million - 140.2 million
Dec. 31, 2025 533.8 million - 143.2 million

ABCL Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2026 318.1 million
June 30, 2026 305.6 million
March 31, 2026 303.1 million
Dec. 31, 2025 298.7 million

ABCL Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 1.6 million 43.5 million 13.6 million -
June 30, 2026 2.1 million 46.0 million 13.9 million -
March 31, 2026 3.8 million 46.7 million 10.5 million -
Dec. 31, 2025 9.8 million 50.1 million 15.4 million 8.8 million

ABCL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 10.6 million -
June 30, 2026 4.1 million -
March 31, 2026 8.3 million 8.7 million
Dec. 31, 2025 44.9 million 7.9 million

ABCL Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ABCL

Price: $11.55

52 week price:
2.75
15.02

Earnings Per Share: -0.48 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 1.3 million

Market Capitalization: 3.9 billion

Links: